FI831253L - Foerfarande foer framstaellning av nya oxazolderivat - Google Patents

Foerfarande foer framstaellning av nya oxazolderivat

Info

Publication number
FI831253L
FI831253L FI831253A FI831253A FI831253L FI 831253 L FI831253 L FI 831253L FI 831253 A FI831253 A FI 831253A FI 831253 A FI831253 A FI 831253A FI 831253 L FI831253 L FI 831253L
Authority
FI
Finland
Prior art keywords
oxazolderivat
nya
foerfarande foer
foer framstaellning
framstaellning
Prior art date
Application number
FI831253A
Other languages
English (en)
Other versions
FI831253A0 (fi
Inventor
Kanji Meguro
Takeshi Fujita
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of FI831253A0 publication Critical patent/FI831253A0/fi
Publication of FI831253L publication Critical patent/FI831253L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI831253A 1982-04-19 1983-04-14 Foerfarande foer framstaellning av nya oxazolderivat FI831253L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57066124A JPS58183676A (ja) 1982-04-19 1982-04-19 オキサゾ−ル誘導体

Publications (2)

Publication Number Publication Date
FI831253A0 FI831253A0 (fi) 1983-04-14
FI831253L true FI831253L (fi) 1983-10-20

Family

ID=13306807

Family Applications (1)

Application Number Title Priority Date Filing Date
FI831253A FI831253L (fi) 1982-04-19 1983-04-14 Foerfarande foer framstaellning av nya oxazolderivat

Country Status (14)

Country Link
US (1) US4596816A (fi)
EP (1) EP0092239A3 (fi)
JP (1) JPS58183676A (fi)
KR (1) KR840004415A (fi)
AU (1) AU1355283A (fi)
CA (1) CA1195985A (fi)
DK (1) DK172183A (fi)
ES (1) ES8603174A1 (fi)
FI (1) FI831253L (fi)
GR (1) GR79251B (fi)
HU (1) HU187002B (fi)
NO (1) NO831361L (fi)
PT (1) PT76563B (fi)
ZA (1) ZA832657B (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4632930A (en) * 1984-11-30 1986-12-30 E. I. Du Pont De Nemours And Company Antihypertensive alkyl-arylimidazole, thiazole and oxazole derivatives
ZW19786A1 (en) * 1985-10-17 1988-05-18 Hoffmann La Roche Heterocyclic compounds
GB8531608D0 (en) * 1985-12-23 1986-02-05 Beecham Group Plc Treatment
US4968707A (en) * 1987-06-10 1990-11-06 Pfizer Inc. Oxazolidin-2-one derivatives as hypoglycemic agents
US5239080A (en) * 1989-02-08 1993-08-24 Takeda Chemical Industries, Ltd. Oxazole compounds and their use as antidiabetic and bone-reduction inhibitory agents
EP0440183A1 (en) * 1990-02-01 1991-08-07 Takeda Chemical Industries, Ltd. Oxazole compounds, their production and use
FR2699172B1 (fr) * 1992-12-11 1995-01-20 Adir Nouveaux dérivés de 4-méthyl-1,3-oxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US6177452B1 (en) 1996-04-03 2001-01-23 Takeda Chemical Industries, Ltd. Oxazole derivatives, their production and use
EP1077958A1 (en) * 1998-05-12 2001-02-28 American Home Products Corporation Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
JP2002514637A (ja) * 1998-05-12 2002-05-21 アメリカン・ホーム・プロダクツ・コーポレイション インスリン耐性および高血糖症の治療に有用なビフェニルスルホニルアリールカルボン酸
US6699896B1 (en) 1998-05-12 2004-03-02 Wyeth Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
IL158168A0 (en) 2001-04-16 2004-03-28 Tanabe Seiyaku Co 5-membered, nitrogen-containing heterocyclic compounds and pharmaceutical compositions containing the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1226548A (fi) * 1967-06-14 1971-03-31 Wyeth John & Brother Ltd
GB1245087A (en) * 1967-10-26 1971-09-02 Wyeth John & Brother Ltd Heterocyclic compounds
US3578671A (en) * 1967-11-06 1971-05-11 Wyeth John & Brother Ltd Oxazoles

Also Published As

Publication number Publication date
HU187002B (en) 1985-10-28
JPS58183676A (ja) 1983-10-26
ES521865A0 (es) 1985-05-16
DK172183A (da) 1983-10-20
US4596816A (en) 1986-06-24
PT76563B (en) 1986-05-07
DK172183D0 (da) 1983-04-19
PT76563A (en) 1983-05-01
ES8603174A1 (es) 1985-05-16
ZA832657B (en) 1984-01-25
CA1195985A (en) 1985-10-29
NO831361L (no) 1983-10-20
GR79251B (fi) 1984-10-22
EP0092239A3 (en) 1985-01-23
KR840004415A (ko) 1984-10-15
EP0092239A2 (en) 1983-10-26
FI831253A0 (fi) 1983-04-14
AU1355283A (en) 1983-10-27

Similar Documents

Publication Publication Date Title
FI833859A0 (fi) Nya azolfoereningar
FI840824A0 (fi) Nya azol-foereningar
FI822173A0 (fi) Nya orala dipyridamolformer
FI822243L (fi) Nya n-aryl-piperazinalkanamider
FI834141A0 (fi) Foerfarande foer framstaellning av nya arylfenyleterderivat
FI831102A0 (fi) Nya quinolonfoereningar och framstaellning av dessa
FI840867A0 (fi) Nya karboxamider
FI821833A0 (fi) Foerfarande foer framstaellning av nya antracykliner
FI811059L (fi) Foerfarande foer framstaellning av nya tricykliska etrar
FI832556A0 (fi) Nya 19-tio-androstanderivat
FI831253A0 (fi) Foerfarande foer framstaellning av nya oxazolderivat
FI822803A0 (fi) Nya karbostyrilderivat
FI821305A0 (fi) Foerfarande foer framstaellning av nya alifatiska fenylkarboxylsyraderivat
FI834666A (fi) Foerfarande foer framstaellning av nya aralkyltriazolfoereningar.
FI823156L (fi) Foerfarande foer framstaellning av nya polycykliska polyazaheterocykler
FI833480A (fi) Nya antracyklinglykosider
FI832374A0 (fi) Foerfarande foer framstaellning av nya fenylaettiksyraderivat
FI834481A0 (fi) Nya etenamidin- och guanidinderivat
FI831778A0 (fi) Nya dihydropyridiner
FI833733A (fi) Foerfaranden foer framstaellning av nya diuretiska/antihypertensiva kompositioner
FI831254A0 (fi) Foerfarande foer framstaellning av nya modifierade leror
FI822215L (fi) Foerfarande foer framstaellning av nya benzoyl-fenyl-piperdinderivat
FI810838L (fi) Foerfarande foer framstaellning av nya isoxazolderivat
FI820339L (fi) Nya apovinkaminolderivat
FI831856A0 (fi) Mekaniskt hjaelpmedel foer utskrift av systemspel

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: TAKEDA CHEMICAL INDUSTRIES LTD